InvestWiser
Navamedic ASA
NAVA · Oslo Børs · Healthcare
13.30NOK
−1.5%last day
Price as of 2 October 2026
Performance
1 month
−2.9%
1 year
−38.1%
3 years, per year
−30.7%
5 years, per year
−11.9%
Largest fall, 3 years
−69.1%
Below the peak now
−68.8%
Volatility, 1 year
36.3%
Return with dividends reinvested.
Key figures
P/E
negative earnings
P/B
1.1
Dividend yield
0.0%
Return on equity
−7.6%
Net margin
−4.0%
Market value
33 m USD
Quality, value and trend
Where Navamedic stands against every Nordic stock today. 100 is best.
14
Profitability and a sound balance sheet over time. Better than 14% of Nordic stocks.
64
The price measured against earnings, assets and cash flow. Better than 64% of Nordic stocks.
8
The price development over the past year. Better than 8% of Nordic stocks.
12
Quality, value and trend together. Better than 12% of Nordic stocks.
About Navamedic
Navamedic ASA is a company in healthcare, listed on Oslo Børs. The share trades in NOK. It has around 38 employees.
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. Its product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics.
See the full analysis in InvestWiser.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
See the full analysis